Börse:
9,707$
-2,73%
Echtzeit-Aktienkurs Concert Pharmaceuticals
Bid:
9,619$
Ask:
9,795$
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 227,52 Mio. EUR (23,44 Mio. x 9,707$) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 1.245,05 | 1,56 | 21,66 |
| KGV | - | 2,39 | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Concert Pharmaceuticals Aktie
Börsenkurse Concert Pharmaceuticals
| Euro Indikation | 8,612€ | 0 | 8,799€ | 0 | 8,706€ | -3,42% |
| Lang & Schwarz | 8,666€ | 1331 | 8,754€ | 1331 | 8,710€ | -3,42% |
| Dollar Indikation | 9,619$ | 0 | 9,795$ | 0 | 9,707$ | -2,73% |
| Börse Stuttgart | 8,608€ | 0 | 8,840€ | 0 | 8,724€ | -3,22% |
Fundamentaldaten der Concert Pharmaceuticals Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 10,51 Mio. | -55,71 Mio. | -56,02 Mio. | -2,40 | 0,00% | - | 21,66 |
| 2017 | 143,89 Mio. | 95,34 Mio. | 95,20 Mio. | 4,06 | 0,00% | 2,39 | 1,56 |
| 2016 | 0,17 Mio. | -50,72 Mio. | -50,72 Mio. | -2,28 | 0,00% | - | 1245,05 |
Profil der Concert Pharmaceuticals Aktie
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs for renal disease, CNS disorders, inflammation and hematologic disorders. It also creates novel medicines that address commercially important needs by applying its deuterated chemical entity platform to compounds with well-characterized pharmacological activity. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen